![Roger Garceau](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roger Garceau
Direktor/Vorstandsmitglied bei
PROTARA THERAPEUTICS, INC.
Vermögen: 126 060 $ am 30.06.2026
Profil
Roger J.
Garceau currently works at Enterome SA, as Independent Director from 2016, Fluorinov Pharmaceuticals, Inc., as Director from 2015, and Protara Therapeutics, Inc., as Independent Director from 2019.
Dr. Garceau also formerly worked at Entera Bio Ltd., as Chief Executive Officer & Director from 2020 to 2021, ArTara Subsidiary, Inc., as Director, and NPS Pharmaceuticals, Inc., as Chief Medical Officer & Executive Vice President from 2014 to 2015.
Dr. Garceau received his undergraduate degree from Fairfield University and doctorate degree from UMass Chan Medical School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.06.2026 | 33’000 ( 0.06% ) | 126 060 $ | 30.06.2026 |
Aktive Positionen von Roger Garceau
| Unternehmen | Position | Beginn |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.01.2020 |
Fluorinov Pharmaceuticals, Inc.
 Fluorinov Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktor/Vorstandsmitglied | 04.05.2015 |
Enterome SA
 Enterome SA Pharmaceuticals: MajorHealth Technology Develops immunomodulatory drugs for treatment of cancer | Direktor/Vorstandsmitglied | 01.12.2016 |
Ehemalige bekannte Positionen von Roger Garceau
| Unternehmen | Position | Ende |
|---|---|---|
| NPS PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2015 |
ArTara Subsidiary, Inc.
 ArTara Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktor/Vorstandsmitglied | - |
| ENTERA BIO LTD. | Vorstandsvorsitzender | 04.01.2021 |
Ausbildung von Roger Garceau
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
38
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for bone and mineral disorders | Health Technology |
Fairfield University
 Fairfield University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enterome SA
Enterome SA Pharmaceuticals: MajorHealth Technology Develops immunomodulatory drugs for treatment of cancer | Health Technology |
UMass Chan Medical School
 UMass Chan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entera Bio Ltd.
 Entera Bio Ltd. Pharmaceuticals: MajorHealth Technology Manufactures flu medicines | Health Technology |
Fluorinov Pharmaceuticals, Inc.
Fluorinov Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
ArTara Subsidiary, Inc.
ArTara Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Protara Therapeutics, Inc.
 Protara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Wählen Sie MarketScreener 
